Transition report pursuant to Rule 13a-10 or 15d-10

Stock-Based Compensation (Tables)

v3.22.0.1
Stock-Based Compensation (Tables)
3 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Fair Value Of Stock Options Granted, Assumptions
The Company determined the fair value of stock options granted during the three months ended December 31, 2020 based upon the assumptions as provided below. No stock options were granted during the three months ended December 31, 2021.
Stock price
$10.00
Exercise price
$10.01
Dividend yield
%
Expected volatility
60  %
Risk-Free interest rate
0.63  %
Expected life (in years)
6.08
Summary of Stock Option Activities
Following is a summary of stock option activities for the three months ended December 31, 2021:
Options Weighted
Average
Exercise Price
Weighted
Average
Grant Date
Fair Value
Weighted
Average
Remaining
Life
(years)
Intrinsic
Value
Outstanding – October 1, 2021
8,978,185  $ 0.19  $ 0.20  5.7 $ 91,699 
Granted —  —  — 
Exercised (893,509) 0.18  0.16 
Forfeited —  —  — 
Outstanding – December 31, 2021
8,084,676  $ 0.19  $ 0.21  5.6 $ 69,875 
Exercisable as of December 31, 2021
8,084,676  $ 0.19  $ 0.21  5.6 $ 69,875 
Summary of Restricted Stock Activity

Restricted Stock Awards
Weighted Average Grant Date
Fair Value
Restricted Stock Units
Weighted Average Grant Date
Fair Value
Non-vested – October 1, 2021 684,937  $ 10.00  1,452,195  $ 7.61 
Granted
—  —  970,545  8.96 
Vested
(684,937) 10.00  (32,848) 7.53 
Forfeited
—  —  (16,369) 8.58 
Non-vested – December 31, 2021
—  $ —  2,373,523  $ 8.22 
Summary of Stock-based Compensation Expense
Stock-based compensation expense for stock options and restricted stock in the unaudited interim condensed consolidated statements of operations is summarized as follows:
Three Months Ended December 31,
2021 2020
Software development
$ 297  $ 18 
General and administrative
2,565  1,257 
Selling and marketing
69 
Total stock-based compensation expense
$ 2,931  $ 1,275